Northern Trust Company of Connecticut’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
Other funds holding AEGR
BFA
EAM
HM
Northern Trust Company of Connecticut's AEGR Position: Q4 2013 in Review
Northern Trust Company of Connecticut increased its Aegerion Pharmaceuticals (AEGR) stake by 35% in Q4 2013, buying an estimated $452K and bringing the position to 22,791 shares worth $1.62M. The position accounts for 0.01% of the portfolio, ranked #1176.
Northern Trust Company of Connecticut first reported a position in AEGR in Q2 2013 and has held it in 3 quarters since. 150 funds tracked by Wall St. Rank hold AEGR as of Q4 2013.
- Northern Trust Company of Connecticut held 22,791 shares of Aegerion Pharmaceuticals worth $1.62M as of Q4 2013.
- Northern Trust Company of Connecticut bought 5,905 Aegerion Pharmaceuticals shares in Q4 2013, an estimated $452K.
- Aegerion Pharmaceuticals made up 0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1176 holding.
- Northern Trust Company of Connecticut first reported a position in Aegerion Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
- 150 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2013.
Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.